Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
Nature Aging
|
April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Petr Novak, Branislav Kovacech, Stanislav Katina, et al.
Ebiomedicine
|
January 25, 2022
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
Branislav Kovacech, Lubica Fialova, Peter Filipcik, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS study
Laura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice
|
August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study
Laura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Natalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Neurobiology of Aging
|
June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse, Staffan Persson, Daniel Alcolea, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
Nature Aging
|
April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Petr Novak, Branislav Kovacech, Stanislav Katina, et al.
Ebiomedicine
|
January 25, 2022
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
Branislav Kovacech, Lubica Fialova, Peter Filipcik, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS study
Laura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice
|
August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study
Laura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Journal of Alzheimer'S Disease : JAD
|
March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Natalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Neurobiology of Aging
|
June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study
Niels Kruse, Staffan Persson, Daniel Alcolea, et al.
Page
of 8